Virtus Fund Advisers’s Meridian Bioscience Inc VIVO Stock Holding History

Virtus Fund Advisers’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-776	Closed	-$25.8K	–	116
2022 Q4	$25.8K	Buy	+776	New	+$25K	0.18%	87
2014 Q3	–	Sell	-3,547	Closed	-$73K	–	2094
2014 Q2	$73K	Buy	+3,547	New	+$72.9K	﹤0.01%	1616

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Virtus Fund Advisers's VIVO Position: Q1 2023 in Review

Virtus Fund Advisers sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 776 shares — an estimated $25.8K sold.

Virtus Fund Advisers first reported a position in VIVO in Q2 2014 and held it in 2 quarters. The position peaked at $73K in Q2 2014. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Virtus Fund Advisers reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Virtus Fund Advisers sold 776 Meridian Bioscience Inc shares in Q1 2023, an estimated $25.8K.
Virtus Fund Advisers first reported a position in Meridian Bioscience Inc in Q2 2014 and held it in 2 quarters.
Virtus Fund Advisers's Meridian Bioscience Inc position peaked at $73K in Q2 2014.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Virtus Fund Advisers's 13F filing for Q1 2023, filed 15 May 2023.